MedDataX Logo

HRQoL Among Patients Amputated Due to Peripheral Arterial Disease

NCT ID: NCT03570788

Last Updated: 2019-06-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

98 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-09-12

Study Completion Date

2019-05-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A prospective cohort study over the prosthetic use among patients amputated after vascular disease and the impact of their HRQoL.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Quality of Life Amputation Peripheral Arterial Disease Prosthesis User

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Amputation

Major amputation defined as at or above ankle

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients amputated at femoral, knee or tibial level due to peripheral arterial disease

Exclusion Criteria

* Patients not able to provide informed consent
* Patients not able to verbally express their experience of the amputation.
* Patients that not speak Swedish
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jonas Malmstedt

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jonas Malmstedt

Co - Principal Investigator, M.D Ph.D.

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eva Torbjörnsson

Role: PRINCIPAL_INVESTIGATOR

Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet

Stockholm, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2014/801-31/1

Identifier Type: -

Identifier Source: org_study_id